Status:

RECRUITING

Validation of the Masimo Irregular Heartbeat Detection Algorithm in Participants Without Cardiovascular Disease

Lead Sponsor:

Masimo Corporation

Conditions:

Healthy

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

Specificity measure of performance of the Irregular Heartbeat Detection algorithm (evaluated for the finger and wrist form factors) against the Masimo Radius VSM® reference ECG. Each form factor will ...

Eligibility Criteria

Inclusion

  • Subject is 18 to 80 years of age.
  • Comfortable to read and communicate in English.\*
  • Subject passes the health assessment conducted by qualified study personnel, confirming they are in adequate health to participate in the required procedures
  • This is to ensure the participant can provide informed consent and can comply with study procedures (as study material are currently available in English only).

Exclusion

  • Subject currently has a known cardiac disease condition.
  • Subject is pregnant or breastfeeding.
  • Subjects with a skin condition affecting the digits/chest, where the sensors are applied which would interfere with the path of lights (e.g., psoriasis, vitiligo, eczema, angioma, scar tissue, burn, fungal infection, substantial skin breakdown) or sensor adhesion.
  • Skin condition which would preclude proper ECG placement.
  • Subjects with nail polish or acrylic nails on the digits where sensor needs to be applied, who opt not to remove them.
  • Subject is allergic to any supplies used in the study (e.g., ECG gel, adhesives).
  • Subject has any medical condition which in the judgment of the investigator and/or study staff, renders them ineligible for participation in this study or subject is deemed ineligible by the discretion of the investigator/study staff.

Key Trial Info

Start Date :

October 21 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 1 2026

Estimated Enrollment :

120 Patients enrolled

Trial Details

Trial ID

NCT07223164

Start Date

October 21 2025

End Date

June 1 2026

Last Update

October 31 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Masimo Corporation

Irvine, California, United States, 92618